Joining forces w other oncologists today (in b/w seeing pts in clinic) as part of the @asco radio tour. Coming live from Atrium Health Levine Cancer 👉🏻 #drugshortages are at critical level, esp #carboplatin #cisplatin 👉🏻 we are begging our lawmakers to intervene! #advocacy 1/2
Been out a while, but better late tweet than never; NPEPPS as target in #cisplatin resistant #bladdercancer in Cancer Research ! By Robert Jones , Tahlita Zuiverloon MD PhD , Dan Theodorescu , Jim Costello. congrats!
NPEPPS Is a Druggable Driver of Platinum Resistance aacrjournals.org/cancerres/arti…
At #ELCC24 we presented a poster on the phI/II study testing inhaled #cisplatin + systemic chemo-IO for pts with tx-naive stage IV #NSCLC 🫁
A trial conducted by InhaTarget Therapeutics, a spin-off from Université libre de Bruxelles w/ several academic hospitals in #Belgium
Institut Jules Bordet Instituut OncoAlert ESMO - Eur. Oncology
Don't miss the new OncLive.com interview with WCM Englander Institute for Precision Medicine's Dr. Scott T. Tagawa (@DrScottTagawa) on 'The Rationale for Investigating First-Line #Nivolumab Plus #Cisplatin in #UrothelialCancer . #PrecisionMedicine
onclive.com/view/dr-tagawa…
Mike Pishvaian Álvaro Lopes de Oliveira #TumorBoardTuesday Integrity CE, LLC yes...therapeutical sequencing is not standard. Cisplatin and etoposide is reserved for more aggressive PPGL, though
#TumorBoardTuesday Rachel Riechelmann Integrity CE, LLC #TumorBoardTuesday
🔁Back to the Case:
💊Cabozantinib for a month and stopped due to G3 diarrhea
Then, cisplatin and etoposide ➡️ 8 cycles: PR, but tx limiting tox!
In this AnnalsSurgOncology #FeaturedArticle , the authors provide a background to consider offering HIPEC with cisplatin 100mg/m3 to selected FIGO stage IV patients and/or patients receiving up to VI cycles of NACT.
📃: ow.ly/Kv9850Rjgj7
I have not worked with a black urologist & I will likely be the first for a lot of my patients. I yearn for diversity within urology. From my cancer survivor expected to becoming a urological oncologist. From cisplatin to surgeon #match2025 #urology #urosome #medtwitter
Bucilliamine by $RVVTF is such a potent cellular protector that it prevents #chemotherapy induced hearing loss.....
This is peer-reviewed independent scientific papers....
nature.com/articles/emm20…
Check our poster 107TiP on a ph 1, first-in-human trial on inhaled #cisplatin to pts with adv #NSCLC , in combo w/ pembro +- IV chemo 🫁
A collaboration between a spin-off biotech from the Univ Libre de Bruxelles Université libre de Bruxelles, Institut Jules Bordet Instituut & other 🇧🇪 centers
ESMO - Eur. Oncology #ELCC24 #lcsm
Hannah - KSJ1 💜 Mike Pishvaian Álvaro Lopes de Oliveira #TumorBoardTuesday Integrity CE, LLC correct. but cisplatin and etoposide are quite toxic so we use CAPTEM 1st for aggressive cases
Are you as excited as we are for ASCO #GI24 posters? Coming up today at 12:30 PT, Memorial Sloan Kettering Cancer Center's Ghassan Abou-Alfa will present the results of a discontinued phase 3 trial of an oral FGFR inhibitor vs. gemcitabine plus cisplatin in patients with advanced cholangiocarcinoma. #cancer
Single-walled carbon nanotubes are described in this study as protective drug carriers which can decrease severe side effects of the anticancer drug Cisplatin. asmedigitalcollection.asme.org/nanoengineerin…
#carbonnanotube
Lizzy trying on her hearing aides for the first time. #SupportResearch #CancerAwareness #CancerBreakthrough #CancerFight [Video] Lizzy lost part of her hearing while going through chemotherapy for Osteosarcoma. Cisplatin, which can manifest as ringing in… dlvr.it/T5rDHF
Come by F3 for our poster on evaluation of provider preferences in 1L cisplatin-ineligible mUC in the setting of platinum shortages University of Illinois Cancer Center UIC Heme Onc Fellowship ASCO #GU24
Nanodrugs based on co-delivery strategies to combat cisplatin resistance.
| Youqing Shen Zhejiang University |
#nanodrug #cisplatin #codelivery
doi.org/10.1016/j.jcon…